icon-folder.gif   Conference Reports for NATAP  
 
  EASL 47th Annual Meeting
April 18th - 22nd 2012
Barcelona, Spain
Back grey_arrow_rt.gif
 
 
 
Use of Telaprevir Plus Peg Interferon/Ribavirin for Null Responders Post OLT With Advanced Fibrosis/Cholestatic Hepatitis C
 
 
  Reported by jules Levin
EASL 2012
 
Kwo PJ1,3, Ghabril M1,3, Lacerda M1,3, Vinayek R1,3, Tector AJ2,3, Fridell J2,3, Vianna R 2,3. 1Medicine, Indiana University School of Medicine, 2Transplant Surgery, Indiana School of Medicine, 3Indiana University Health, Indianapolis, IN USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif